Blastoid Variant Mantle Cell Lymphoma

Explore clinical trials studying Blastoid Variant Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Blastoid Variant Mantle Cell Lymphoma trial results

Recruiting

NCT05861050

Conditions: Blastoid Variant Mantle Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: City of Hope Medical Center Duarte, California, United States

Mount Sinai School of Medicine New York, United States

Huntsman Cancer Institute Salt Lake City, Utah, United States

Completed

NCT02869633

Conditions: Blastoid Variant Mantle Cell Lymphoma, Chronic Disease, Disease Attributes, +27 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Stanford Cancer Institute Palo Alto, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

Active, Not Recruiting

NCT02427620

Conditions: Blastoid Variant Mantle Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Active, Not Recruiting

NCT03946878

Conditions: Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive, +16 more
Locations: M D Anderson Cancer Center Houston, Texas, United States